Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

611 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gemcitabine monotherapy as second-line treatment in cisplatin-refractory transitional cell carcinoma - prognostic factors for response and improvement of quality of life.
Albers P, Siener R, Härtlein M, Fallahi M, Haeutle D, Perabo FG, Steiner G, Blatter J, Müller SC; German TCC Study Group of the German Association of Urologic Oncology. Albers P, et al. Onkologie. 2002 Feb;25(1):47-52. doi: 10.1159/000055202. Onkologie. 2002. PMID: 11893883 Clinical Trial.
Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99].
Albers P, Park SI, Niegisch G, Fechner G, Steiner U, Lehmann J, Heimbach D, Heidenreich A, Fimmers R, Siener R; AUO Bladder Cancer Group. Albers P, et al. Ann Oncol. 2011 Feb;22(2):288-94. doi: 10.1093/annonc/mdq398. Epub 2010 Aug 2. Ann Oncol. 2011. PMID: 20682548 Free article. Clinical Trial.
611 results